latest news in Dermatology

Galderma Targets Accelerated Expansion as U.S. Wrinkle Treatment Filing Approaches

Galderma Targets Accelerated Expansion as U.S. Wrinkle Treatment Filing Approaches

Zurich, Thursday, 19 November 2026.
Galderma signaled sustained growth through 2027, driven by international expansion, selective acquisitions, and plans to file its Botox competitor, Relfydess, in the United States in early 2027.